{
    "medicine_id": "e2eae472a01e4614f15f2a9fccddef991abcd7dc",
    "platform_id": "DB01194",
    "metadata": {
        "name": "Azarga 5 MG ML Solution drops",
        "composition": "5 MG ML Brinzolamide",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of elevated intraocular pressure in patients with ocular hypertension or open angle glaucoma",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Used in the treatment of glaucoma brinzolamide inhibits aqueous humor formation and reduces elevated intraocular pressure Elevated intraocular pressure is a major risk factor in the pathogenesis of optic nerve damage and glaucomatous visual field loss Brinzolamide can decrease intraocular pressure by approximately 16 19 in patients with elevated intraocular pressure",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00273",
                        "description": "The risk or severity of adverse effects can be increased when Topiramate is combined with Brinzolamide"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Brinzolamide can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The therapeutic efficacy of Brinzolamide can be decreased when used in combination with Meloxicam"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be decreased when it is combined with Brinzolamide"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Brinzolamide can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB01053",
                        "description": "Brinzolamide may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The serum concentration of Haloperidol can be increased when it is combined with Brinzolamide"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Brinzolamide"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The risk or severity of CNS depression can be increased when Brinzolamide is combined with Ziconotide"
                    },
                    {
                        "drugbank-id": "DB09038",
                        "description": "Empagliflozin may increase the diuretic activities of Brinzolamide"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Brinzolamide can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The therapeutic efficacy of Brinzolamide can be decreased when used in combination with Oliceridine"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Brinzolamide can be decreased when it is combined with Satralizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}